Comparing setup time and patient preferences for SCIg therapy: a head-to-head cross-sectional evaluation of two SC pumps.

BACKGROUND

This study compares the setup time and steps of two different subcutaneous infusion pumps using a 50 mL prefilled syringe (or PFS).

METHODS

This cross-sectional time and motion assessment followed by a survey gathered patient setup time, number of steps, and surveyed preference for the FREEDOM60 ("Pump A"; manufactured by KORU Medical Systems, Inc.) and SCIg60 ("Pump B"; manufactured by EMED Technologies Corporation) pump for subcutaneous immunoglobulin (SCIg) therapy. Participants were recruited from the Immune Deficiency Foundation (IDF) patient network. Participants provided informed consent, engaged in a hands-on demonstration, and completed a self-administered survey.

RESULTS

89% reported faster setup times with the Pump A infusion system, resulting in time efficiency improvements. Fast and easy setup, portability, and minimal steps were highly valued and influenced patient satisfaction. Challenges included pump malfunction and complex setup. Patients preferred prefilled syringes due to ease and potential error reduction. Fast setup time was important for arthritis management, reducing stress, work accommodation, and caregiver assistance.

CONCLUSION

A significant majority (78%) of patients preferred Pump A over Pump B. It showed advantages in load/unload setup time, resulting in time savings and increased efficiency for SCIg therapy. Incorporating Pump A may enhance treatment adherence and satisfaction, improving outcomes in primary immunodeficiency (PID) management.